Gracure Pharmaceuticals Limited — Tramadol Exporter Profile
Indian Pharmaceutical Exporter · #8 for Tramadol · $5.6M export value · DGFT Verified
Gracure Pharmaceuticals Limited is the #8 Indian exporter of Tramadol with $5.6M in export value and 124 verified shipments. Gracure Pharmaceuticals Limited holds a 1.5% market share in Tramadol exports across 4 countries. The company exports 17 pharmaceutical products worth $28.1M across 9 therapeutic categories.
Gracure Pharmaceuticals Limited — Tramadol Export Profile: Buyers & Destinations
Where Does Gracure Pharmaceuticals Limited Export Tramadol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BELGIUM | $2.6M | 104 | 84.5% |
| VIETNAM DEMOCRATIC REP. OF | $159.2K | 8 | 5.3% |
| NIGERIA | $147.3K | 4 | 4.9% |
| VIETNAM, DEMOCRATIC REP. OF | $92.3K | 4 | 3.1% |
| VIETNAM | $58.8K | 3 | 1.9% |
| TANZANIA | $10.4K | 1 | 0.3% |
Gracure Pharmaceuticals Limited exports Tramadol to 6 countries. The largest destination is BELGIUM accounting for 84.5% of Gracure Pharmaceuticals Limited's Tramadol shipments, followed by VIETNAM DEMOCRATIC REP. OF (5.3%) and NIGERIA (4.9%). These destinations reflect Gracure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Tramadol from Gracure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EXPHAR SANIVELLES SUD ZONE II THINES | BELGIUM | $250.1K | 10 |
| EXPHAR LAB LIMITED | NIGERIA | $147.3K | 4 |
| HANOI CPC1 PHARMACEUTICAL JSC | VIETNAM DEMOCRATIC REP. OF | $71.5K | 3 |
| CENTRAL PHARMACEUTICAL CPC1 JSC | VIETNAM, DEMOCRATIC REP. OF | $48.9K | 4 |
| CAMEL INTERNATIONAL IM- EXPORT CO. | VIETNAM DEMOCRATIC REP. OF | $43.5K | 1 |
| CENTRAL PHARMACEUTICAL | VIETNAM | $29.5K | 2 |
| CAMEL INTERNATIONAL IM-EXPORT CO | VIETNAM | $29.3K | 1 |
| CAMEL INTERNATIONAL IM-EXPORT CO.,L | VIETNAM, DEMOCRATIC REP. OF | $26.2K | 1 |
| HA NOI CPC1 PHARMACEUTICAL JOINT ST | VIETNAM, DEMOCRATIC REP. OF | $24.9K | 1 |
| HA NOI CPC1 PHARMACEUTICAL | VIETNAM, DEMOCRATIC REP. OF | $18.3K | 1 |
Gracure Pharmaceuticals Limited supplies Tramadol to 19 buyers globally. The largest buyer is EXPHAR SANIVELLES SUD ZONE II THINES (BELGIUM), followed by EXPHAR LAB LIMITED (NIGERIA) and HANOI CPC1 PHARMACEUTICAL JSC (VIETNAM DEMOCRATIC REP. OF). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Tramadol Export Value and How Much Does Gracure Pharmaceuticals Limited Contribute?
India exported $67.2M worth of Tramadol through 3,928 shipments from 249 suppliers to 103 countries, serving 789 buyers globally. Gracure Pharmaceuticals Limited contributes $5.6M to this total, accounting for 1.5% of India's Tramadol exports. Gracure Pharmaceuticals Limited ships Tramadol to 6 countries through 19 buyers.
What Is the Average Shipment Value for Gracure Pharmaceuticals Limited's Tramadol Exports?
Gracure Pharmaceuticals Limited's average Tramadol shipment value is $44.8K per consignment, based on 124 shipments totaling $5.6M. The largest destination is BELGIUM (84.5% of Gracure Pharmaceuticals Limited's Tramadol exports).
How Does Gracure Pharmaceuticals Limited Compare to Other Indian Tramadol Exporters?
Gracure Pharmaceuticals Limited ranks #8 among 249 Indian Tramadol exporters with a 1.5% market share. The top 3 exporters are RUBICON RESEARCH PRIVATE LIMITED ($11.4M), UNICHEM LABORATORIES LIMITED ($10.3M), MEDREICH LIMITED ($8.2M). Gracure Pharmaceuticals Limited processed 124 shipments to 4 destination countries.
What Tramadol Formulations Does Gracure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ANTALGEX-T B/2X10 CAPSULES (TRAMADOL HYD | $694.2K | 16 |
| ANTALGEX T B 2X10 CAPSULES TRAMADOL HYDROCHLORIDE 37 50 MG PARACETAMOL 325 MG | $150.0K | 3 |
| ANTALGEX-T B/2X10 CAPSULES (TRAMADOL HYDROCHLORIDE 37.50 MG PARACETAMOL 325 MG | $150.0K | 3 |
| ANTALGEX-T B/2X10 CAP(TRAMADOL HCL.37.50MG PARACETAMOL 325MG)B.N.AC240069A TO AC240073A,M.D.03/24,04/24,E.D.02/27,03/27 | $145.5K | 3 |
| ANTALGEX-T B/2X10 CAP.(TRAMADOL HYDROCHLORIDE 37.50MG PARACETAMOL 325MG)B.N.AC230217A,TO AC230221A,M.D.12/23,E.D.11/26NOS | $145.3K | 3 |
| ANTALGEX-T B/2X10CAP(TRAMADOL HYDROCHLORIDE 37.50MG PARACETAMOL 325MG B.N.AC240013A TO AC240017A M.D.01/24,E.D.12/26NOS | $145.3K | 3 |
| ANTALGEX-T B/2X10 CAP(TRAMADOL HYDROCHLORIDE 37.50MG PARACETAMOL 325MG,B.NO.AC240097A TO AC240101A,M.DT.05/24,E.DT.04/27 | $140.4K | 3 |
| ANTALGEX-T B/2X10 CAP.(TRAMADOL HYD.37.5 | $100.0K | 3 |
| ANTALGEX-T B/2X10 CAPSULES(TRAMADOL HYDR | $100.0K | 2 |
| ANTALGEX-T B/2X10 CAP.(TRAMADOL HCL 37.50 MG PARACETAMOL .325 MG)BN.AC240001A,AC240002A,AC240003A MD.01/24 ED.12/26 | $97.3K | 3 |
Gracure Pharmaceuticals Limited exports 75 distinct Tramadol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ANTALGEX-T B/2X10 CAPSULES (TRAMADOL HYD with 16 shipments worth $694.2K.
Regulatory Requirements: Exporting Tramadol to Key Markets
What Gracure Pharmaceuticals Limited must comply with to export Tramadol to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Gracure Pharmaceuticals Limited Compare to Nearest Tramadol Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | UNICHEM LABORATORIES LIMITED | $10.3M | 217 | 9 | $47.3K |
| 6 | MEDREICH LIMITED | $8.2M | 229 | 9 | $35.8K |
| 8 | GRACURE PHARMACEUTICALS LIMITED ★ | $5.6M | 124 | 4 | $44.8K |
| 9 | ZYDUS LIFESCIENCES LIMITED | $5.5M | 208 | 13 | $26.5K |
| 7 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $5.1M | 102 | 4 | $50.0K |
Gracure Pharmaceuticals Limited ranks #8 among 249 Indian Tramadol exporters. Average shipment value of $44.8K compared to the market average of $270.0K. The closest competitors by value are UNICHEM LABORATORIES LIMITED and MEDREICH LIMITED.
Which Indian Ports Ship Tramadol Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 463 | 11.8% |
| SAHAR AIR | 405 | 10.3% |
| JNPT/ NHAVA SHEVA SEA | 289 | 7.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 264 | 6.7% |
| JNPT | 199 | 5.1% |
| MUNDRA SEA | 150 | 3.8% |
| VIZAG SEA | 108 | 2.7% |
| BANGALORE ICD | 106 | 2.7% |
What Other Analgesics & Antipyretics Products Does Gracure Pharmaceuticals Limited Export?
Gracure Pharmaceuticals Limited also exports these analgesics & antipyretics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Gracure Pharmaceuticals Limited's Tramadol Exports
Recent geopolitical tensions, particularly in the Middle East, have significantly impacted global shipping routes. The Red Sea crisis and Houthi attacks have led to increased shipping costs and extended transit times for Indian exporters. Major carriers have suspended or restricted transits through the Red Sea–Suez Canal corridor, resulting in transit times extending by 10–20 days and freight rates rising by 40–50% on key India–Europe routes. (livemint.com)
For Gracure Pharmaceuticals, which relies heavily on maritime routes for its exports, these disruptions pose challenges in maintaining timely deliveries and managing increased operational costs. Additionally, the U.S.–India diplomatic and trade crisis, marked by the imposition of tariffs on Indian exports, further complicates the export landscape. The U.S. administration imposed a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) These developments necessitate strategic adjustments to mitigate potential revenue losses and sustain market competitiveness.
Gracure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Gracure Pharmaceuticals has secured approvals and clearances from various international regulatory bodies, reflecting its commitment to quality and safety. However, evolving regulations, such as the European Union's falsified medicines directive, impose additional compliance requirements. Adhering to these standards is crucial for maintaining market access and consumer trust.
Furthermore, the U.S. Food and Drug Administration (FDA) has intensified scrutiny of foreign pharmaceutical manufacturers. Ensuring compliance with FDA regulations is essential for Gracure to sustain and expand its presence in the lucrative U.S. market.
About Gracure Pharmaceuticals Limited
Gracure Pharmaceuticals Limited exports 17 products worth $28.1M. Beyond Tramadol, top products include Albendazole, Folic, Melatonin, Celecoxib, Doxycycline. View the complete Gracure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tramadol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tramadol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Gracure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 124 individual customs records matching Gracure Pharmaceuticals Limited exporting Tramadol, covering 75 formulations to 6 countries via 19 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 103+ countries, 789+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tramadol Export Data from Gracure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Gracure Pharmaceuticals Limited's Tramadol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Gracure Pharmaceuticals Limited
Full Company Profile →
17 products · $28.1M total trade · 9 categories
Tramadol Stats
Company Overview
Top Products by Gracure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Gracure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tramadol. For current shipment-level data, contact TransData Nexus.